Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV001807956 | SCV002058274 | pathogenic | Recessive dystrophic epidermolysis bullosa | 2022-01-03 | criteria provided, single submitter | clinical testing | Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). The variant has been reported to be associated with COL7A1 related disorder in a similarly affected individual (3billion dataset). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). In addition, patient's phenotype is considered compatible with epidermolysis bullosa dystrophica.Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |